Novavax rises after lifting annual revenue forecast

Novavax

06/11/2025 14:46

** Shares of vaccine maker Novavax NVAX.O rise 1.4% to $7.79 in early trading

** Co now expects its 2025 adjusted revenue to be between $1.04 billion and $1.06 billion, compared with a range of $1 billion to $1.05 billion earlier

** Net loss for the quarter ended September 30 widened to $202 million from $121 million a year earlier

** Co's quarterly revenue of $70 billion beats analysts' average expectation of $42.13 million - LSEG data

** Including session's move, stock down ~4% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))